Chen Y, Zhu L, Wang Y, Hu J, Zhang H, Zhu J
Gland Surg. 2024; 13(3):325-339.
PMID: 38601284
PMC: 11002474.
DOI: 10.21037/gs-23-387.
Li H, Chen Y, Hu L, Yang W, Gao Z, Liu M
Eur J Med Res. 2023; 28(1):392.
PMID: 37773165
PMC: 10542235.
DOI: 10.1186/s40001-023-01287-0.
Dutta S, Shah R, Singhal S, Dutta S, Bansal S, Sinha S
Drug Des Devel Ther. 2023; 17:1907-1932.
PMID: 37397787
PMC: 10312383.
DOI: 10.2147/DDDT.S409373.
Kar S, Maji N, Sen K, Roy S, Maity A, Ghosh Dastidar S
Biosci Rep. 2023; 43(8).
PMID: 37222403
PMC: 10407156.
DOI: 10.1042/BSR20230677.
Xia S, Ma Y
J Oncol. 2022; 2022:9973519.
PMID: 36199790
PMC: 9529396.
DOI: 10.1155/2022/9973519.
Response of neuroblastoma cells to RF currents as a function of the signal frequency.
Hernandez-Bule M, Medel E, Colastra C, Roldan R, Ubeda A
BMC Cancer. 2019; 19(1):889.
PMID: 31488097
PMC: 6728948.
DOI: 10.1186/s12885-019-6090-6.
Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
Wang L, Dai G, Yang J, Wu W, Zhang W
Med Sci Monit. 2018; 24:4046-4053.
PMID: 29899322
PMC: 6032799.
DOI: 10.12659/MSM.909452.
Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt.
Li Z, Wang L, Luo N, Zhao Y, Li J, Chen Q
Oncol Lett. 2018; 15(5):7948-7954.
PMID: 29725482
PMC: 5920475.
DOI: 10.3892/ol.2018.8297.
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu Y
Mol Cancer. 2017; 16(1):52.
PMID: 28245823
PMC: 5331747.
DOI: 10.1186/s12943-017-0624-9.
Role of Annexin A2 in the EGF-induced epithelial-mesenchymal transition in human CaSki cells.
Cui L, Song J, Wu L, Cheng L, Chen A, Wang Y
Oncol Lett. 2017; 13(1):377-383.
PMID: 28123570
PMC: 5244908.
DOI: 10.3892/ol.2016.5406.
Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.
Cooke N, Spillane C, Sheils O, OLeary J, Kenny D
BMC Cancer. 2015; 15:627.
PMID: 26353776
PMC: 4565001.
DOI: 10.1186/s12885-015-1634-x.
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.
Feitelson M, Arzumanyan A, Kulathinal R, Blain S, Holcombe R, Mahajna J
Semin Cancer Biol. 2015; 35 Suppl:S25-S54.
PMID: 25892662
PMC: 4898971.
DOI: 10.1016/j.semcancer.2015.02.006.
Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.
Han B, Cui H, Kang L, Zhang X, Jin Z, Lu L
Tumour Biol. 2015; 36(8):6295-304.
PMID: 25854169
DOI: 10.1007/s13277-015-3315-4.
TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
Xiao H, Jiang N, Zhou B, Liu Q, Du C
Cancer Sci. 2014; 106(2):151-9.
PMID: 25495189
PMC: 4399022.
DOI: 10.1111/cas.12587.
Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.
Zhao Z, Cheng X, Wang Y, Han R, Li L, Xiang T
PLoS One. 2014; 9(4):e95884.
PMID: 24789104
PMC: 4005743.
DOI: 10.1371/journal.pone.0095884.
BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma.
Xiao H, Cheng S, Tong R, Lv Z, Ding C, Du C
Lab Invest. 2013; 94(3):252-61.
PMID: 24365746
DOI: 10.1038/labinvest.2013.151.
Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.
Mimeault M, Batra S
Cancer Epidemiol Biomarkers Prev. 2013; 23(2):234-54.
PMID: 24273063
PMC: 3977531.
DOI: 10.1158/1055-9965.EPI-13-0785.
Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
Mimeault M, Batra S
Mol Aspects Med. 2013; 39:3-32.
PMID: 23994756
PMC: 3938987.
DOI: 10.1016/j.mam.2013.08.001.
IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z, Yang M, Chen R, Su W, Li P, Chen S
Oncogene. 2013; 33(26):3374-82.
PMID: 23975422
PMC: 4078416.
DOI: 10.1038/onc.2013.337.
Differential remodeling of cadherins and intermediate cytoskeletal filaments influence microenvironment of solid and ascitic sarcoma.
Chaklader M, Pan A, Law A, Chattopadhayay S, Chatterjee R, Law S
Mol Cell Biochem. 2013; 382(1-2):293-306.
PMID: 23861106
DOI: 10.1007/s11010-013-1750-3.